| scholarly article | Q13442814 |
| P50 | author | Simon N. Waddington | Q37835224 |
| John H. McVey | Q40442623 | ||
| Alan L Parker | Q55324134 | ||
| Stuart A Nicklin | Q55859805 | ||
| Suzanne M Buckley | Q58227963 | ||
| P2093 | author name string | Andrew H Baker | |
| Menzo Havenga | |||
| P2860 | cites work | The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction | Q24291966 |
| HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses | Q24312224 | ||
| Adenovirus Binding to Blood Factors Results in Liver Cell Infection and Hepatotoxicity | Q27469833 | ||
| Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5 | Q28303765 | ||
| Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment | Q29615852 | ||
| Exploiting the natural diversity in adenovirus tropism for therapy and prevention of disease | Q30830095 | ||
| Long-term stable correction of low-density lipoprotein receptor-deficient mice with a helper-dependent adenoviral vector expressing the very low-density lipoprotein receptor | Q32129558 | ||
| Reducing the native tropism of adenovirus vectors requires removal of both CAR and integrin interactions | Q33849565 | ||
| The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors. | Q35899034 | ||
| The influence of adenovirus fiber structure and function on vector development for gene therapy | Q36182171 | ||
| Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes | Q40264847 | ||
| Adenovirus type 5 interactions with human blood cells may compromise systemic delivery. | Q40297306 | ||
| Effect of adenovirus serotype 5 fiber and penton modifications on in vivo tropism in rats | Q40528538 | ||
| Combined transductional and transcriptional targeting improves the specificity of transgene expression in vivo | Q40782543 | ||
| Influence of coagulation factor zymogens on the infectivity of adenoviruses pseudotyped with fibers from subgroup D. | Q41900381 | ||
| A targetable, injectable adenoviral vector for selective gene delivery to pulmonary endothelium in vivo | Q42833222 | ||
| The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants. | Q44717204 | ||
| Rapid Kupffer cell death after intravenous injection of adenovirus vectors | Q45119497 | ||
| Titer determination of Ad5 in blood: a cautionary note | Q45862533 | ||
| CD46 is a cellular receptor for group B adenoviruses | Q45869560 | ||
| Sequestration of adenoviral vector by Kupffer cells leads to a nonlinear dose response of transduction in liver | Q45874045 | ||
| Bioluminescence imaging reveals a significant role for complement in liver transduction following intravenous delivery of adenovirus | Q45877055 | ||
| Targeting of adenovirus vectors to tumor cells does not enable efficient transduction of breast cancer metastases | Q64379110 | ||
| P433 | issue | 17 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Adenoviridae | Q193447 |
| P304 | page(s) | 9568-9571 | |
| P577 | publication date | 2007-06-06 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Targeting of adenovirus serotype 5 (Ad5) and 5/47 pseudotyped vectors in vivo: fundamental involvement of coagulation factors and redundancy of CAR binding by Ad5 | |
| P478 | volume | 81 |
| Q34701038 | Adrenal gland infection by serotype 5 adenovirus requires coagulation factors |
| Q37859842 | Advances and future challenges in adenoviral vector pharmacology and targeting |
| Q34282191 | Biodistribution and retargeting of FX-binding ablated adenovirus serotype 5 vectors |
| Q28744246 | Cell entry and trafficking of human adenovirus bound to blood factor X is determined by the fiber serotype and not hexon:heparan sulfate interaction |
| Q50977875 | Challenges and Prospects for Helper-Dependent Adenoviral Vector-Mediated Gene Therapy. |
| Q34597583 | Clearance of adenovirus by Kupffer cells is mediated by scavenger receptors, natural antibodies, and complement |
| Q39462577 | Coagulation factor IX mediates serotype-specific binding of species A adenoviruses to host cells |
| Q39892766 | Coagulation factors IX and X enhance binding and infection of adenovirus types 5 and 31 in human epithelial cells |
| Q33440718 | Defining a Novel Role for the Coxsackievirus and Adenovirus Receptor in Human Adenovirus Serotype 5 Transduction In Vitro in the Presence of Mouse Serum |
| Q35107329 | Differential effects of murine and human factor X on adenovirus transduction via cell-surface heparan sulfate |
| Q39926337 | Effect of neutralizing sera on factor x-mediated adenovirus serotype 5 gene transfer |
| Q38897929 | Expression of an engineered soluble coxsackievirus and adenovirus receptor by a dimeric AAV9 vector inhibits adenovirus infection in mice |
| Q42146790 | FX and host defense evasion tactics by adenovirus |
| Q37945218 | Gene therapy with helper-dependent adenoviral vectors: current advances and future perspectives |
| Q40119187 | Gene-therapy delivery strategies in cardiology |
| Q35086122 | Generation of a Kupffer cell-evading adenovirus for systemic and liver-directed gene transfer |
| Q37582126 | Helper-Dependent Adenoviral Vectors. |
| Q35096275 | Hexon modification to improve the activity of oncolytic adenovirus vectors against neoplastic and stromal cells in pancreatic cancer |
| Q37291653 | Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer |
| Q35641791 | Incorporation of Peptides Targeting EGFR and FGFR1 into the Adenoviral Fiber Knob Domain and Their Evaluation as Targeted Cancer Therapies |
| Q39502394 | Influence of coagulation factor x on in vitro and in vivo gene delivery by adenovirus (Ad) 5, Ad35, and chimeric Ad5/Ad35 vectors |
| Q39682767 | Integrin alphavbeta5 is a primary receptor for adenovirus in CAR-negative cells |
| Q37984486 | Manipulation of adenovirus interactions with host factors for gene therapy applications |
| Q34667746 | Mutation of the fiber shaft heparan sulphate binding site of a 5/3 chimeric adenovirus reduces liver tropism |
| Q45879870 | Non-heparan sulfate GAG-dependent infection of cells using an adenoviral vector with a chimeric fiber conserving its KKTK motif. |
| Q26776553 | Oncolytic Adenovirus: Strategies and Insights for Vector Design and Immuno-Oncolytic Applications |
| Q37448942 | Oncolytic adenoviral gene therapy in ovarian cancer: why we are not wasting our time |
| Q92020016 | Patchy Amphiphilic Dendrimers Bind Adenovirus and Control Its Host Interactions and in Vivo Distribution |
| Q35238390 | Perinatal gene transfer to the liver |
| Q33713401 | Redundant and synergistic mechanisms control the sequestration of blood-born adenovirus in the liver |
| Q34699410 | Retargeting adenoviral vectors to improve gene transfer into tumors |
| Q39971490 | Substitution of hexon hypervariable region 5 of adenovirus serotype 5 abrogates blood factor binding and limits gene transfer to liver |
| Q35015807 | The AAV9 receptor and its modification to improve in vivo lung gene transfer in mice |
| Q38230901 | The importance of coagulation factors binding to adenovirus: historical perspectives and implications for gene delivery |
| Q33655401 | The influence of innate and pre-existing immunity on adenovirus therapy |
| Q39669977 | The liver as a target organ for gene therapy: state of the art, challenges, and future perspectives |
| Q37641568 | The role of liver sinusoidal cells in hepatocyte-directed gene transfer |
| Q36955901 | Therapeutic potential of replication-selective oncolytic adenoviruses on cells from familial and sporadic desmoid tumors |
| Q28539158 | Traceless bioresponsive shielding of adenovirus hexon with HPMA copolymers maintains transduction capacity in vitro and in vivo |
| Q38614156 | Tropism-modification strategies for targeted gene delivery using adenoviral vectors |
| Q33586303 | Vector and helper genome rearrangements occur during production of helper-dependent adenoviral vectors |
| Q37087304 | With a little help from my f(X)riends!: the basis of Ad5-mediated transduction of the liver revealed |
Search more.